WHEAT RIDGE, Colo., Oct. 8 /PRNewswire-FirstCall/ -- GeneThera, Inc. (Pink Sheets: GTHR), a molecular biotechnology company, today announced that the company's Chairman and CEO, Dr. Tony Milici, is featured in an exclusive interview on WallSt.net's 3-Minute Press Show.
The interview gives viewers an overview of the company, and the
significance of the company's latest press release.
To view the clip in its entirety, visit: http://www.tv.wallst.net/r/3-minute-press/A-Milici-GTHR-PK/285/1134
Ask Dr. Tony Milici a question, post a comment on his personal page, and join his financial social network today at: http://my.wallst.net/A-Milici-GTHR-PK
About GeneThera, Inc.:
GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression system, GES, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GES is designed for a host of individual diseases, the current priority being Mad Cow disease, Chronic Wasting Disease, E.Coli 0157:H7 and Johne's disease, all diseases affecting cattle worldwide.
About WallStreet Direct, Inc.
WallStreet Direct, Inc. operates WallSt.net (http://www.wallst.net), a
leading source of up-to-the-minute business news, comprehensive financial
tools and original multimedia content for the investment community. In
addition to WallSt.net, WallStreet Direct owns and operates WallStRadio
|SOURCE GeneThera, Inc.; WallStreet Direct, Inc.|
Copyright©2008 PR Newswire.
All rights reserved